Clinical Trial

Ultrasound Therapy In Cardiac Amyloidosis

Study acronym: UTICA
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a prospective pilot clinical study of subjects with cardiac amyloidosis and control subjects without amyloidosis where we plan to evaluate changes in myocardial blood flow, systolic and diastolic function before and after sonotherapy.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2020-12-08; most recent amendment 2025-11-13.
Status change: Not Yet Recruiting → Recruiting 2023-07-25
Trial Details
NCT Number NCT04667494
Lead Sponsor Brigham and Women's Hospital
Conditions Amyloidosis Cardiac
Enrollment 70 participants
Start Date 2023-08-31
Primary Completion 2026-04-30 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-14